Bryan Dechairo Envisions an Accessible Future for CRISPR Diagnostics

CRISPR Cuts

English - September 06, 2022 12:00 - 35 minutes - 32.5 MB - ★★★★★ - 31 ratings
Life Sciences Science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Ayal Hendel Talks About CRISPR in Bubble Boy Disease

Next Episode: Christian Groendahl On Pioneering a CRISPR-based Microbial Gene Therapy

In this episode, Bryan Dechairo, CEO of Sherlock Biosciences, talks about the impact of technology advances in the field of CRISPR diagnostics, his experiences leading Sherlock Biosciences, and his team’s mission of accessibility.